David X. Lee

602 total citations · 1 hit paper
7 papers, 287 citations indexed

About

David X. Lee is a scholar working on Infectious Diseases, Modeling and Simulation and Genetics. According to data from OpenAlex, David X. Lee has authored 7 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Modeling and Simulation and 2 papers in Genetics. Recurrent topics in David X. Lee's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and COVID-19 epidemiological studies (3 papers). David X. Lee is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and COVID-19 epidemiological studies (3 papers). David X. Lee collaborates with scholars based in United States and Cuba. David X. Lee's co-authors include Marcel E. Curlin, William B. Messer, Zoë L. Lyski, Savannah K. McBride, Fikadu Tafesse, Timothy A. Bates, Hans C. Leier, Devin Schoen, Gaelen Guzman and Joon‐Yong Lee and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

David X. Lee

7 papers receiving 282 citations

Hit Papers

Vaccination before or after SARS-CoV-2 infection leads to... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David X. Lee United States 5 272 49 47 36 35 7 287
David Hillus Germany 4 282 1.0× 39 0.8× 45 1.0× 20 0.6× 33 0.9× 8 300
Savannah K. McBride United States 8 358 1.3× 58 1.2× 62 1.3× 49 1.4× 39 1.1× 9 383
Cindy Wu United States 2 259 1.0× 73 1.5× 29 0.6× 24 0.7× 30 0.9× 3 289
Ivan Fan Ngai Hung China 4 268 1.0× 24 0.5× 38 0.8× 29 0.8× 22 0.6× 4 303
Bosco Lam China 4 262 1.0× 23 0.5× 38 0.8× 29 0.8× 21 0.6× 6 298
Lara Walotka Germany 5 303 1.1× 39 0.8× 65 1.4× 50 1.4× 51 1.5× 8 388
Maren Bacher Germany 3 358 1.3× 67 1.4× 53 1.1× 25 0.7× 44 1.3× 4 380
Laura Ziegler Germany 4 250 0.9× 42 0.9× 73 1.6× 14 0.4× 61 1.7× 4 280
Julia Barrett United States 5 281 1.0× 84 1.7× 32 0.7× 24 0.7× 30 0.9× 8 319
Ashley Otter United Kingdom 8 207 0.8× 48 1.0× 35 0.7× 18 0.5× 28 0.8× 21 277

Countries citing papers authored by David X. Lee

Since Specialization
Citations

This map shows the geographic impact of David X. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David X. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David X. Lee more than expected).

Fields of papers citing papers by David X. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David X. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David X. Lee. The network helps show where David X. Lee may publish in the future.

Co-authorship network of co-authors of David X. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of David X. Lee. A scholar is included among the top collaborators of David X. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David X. Lee. David X. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lee, David X., et al.. (2025). Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19. PubMed. 2(1). 100048–100048. 1 indexed citations
2.
Thomas, Archana, David X. Lee, Steven C. Kazmierczak, et al.. (2024). Contralateral second dose improves antibody responses to a 2-dose mRNA vaccination regimen. Journal of Clinical Investigation. 134(6). 9 indexed citations
3.
Bates, Timothy A., Hans C. Leier, Savannah K. McBride, et al.. (2023). An extended interval between vaccination and infection enhances hybrid immunity against SARS-CoV-2 variants. JCI Insight. 8(5). 20 indexed citations
4.
Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2022). Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia. SHILAP Revista de lepidopterología. 2022. 1–5. 2 indexed citations
5.
Bates, Timothy A., Savannah K. McBride, Hans C. Leier, et al.. (2022). Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Science Immunology. 7(68). eabn8014–eabn8014. 173 indexed citations breakdown →
6.
Lyski, Zoë L., Myung Sun Kim, David X. Lee, et al.. (2021). Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Blood Advances. 6(4). 1207–1211. 11 indexed citations
7.
Bates, Timothy A., Hans C. Leier, Zoë L. Lyski, et al.. (2021). Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum. Nature Communications. 12(1). 5135–5135. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026